MKD - HIVE Blockchain Technologies Molecular Data Evoke Pharma among premarket losers' pack
HIVE Blockchain Technologies (HIVE) -79%. Molecular Data (MKD) -27% on ADS ratio change Evoke Pharma (EVOK) -22% after real-world data analysis reveals a lower risk of Tardive Dyskinesia with metoclopramide. NeuroMetrix (NURO) -9%. Immix Biopharma (IMMX) -7%.
For further details see:
HIVE Blockchain Technologies, Molecular Data, Evoke Pharma among premarket losers' pack